FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049361319> ?p ?o ?g. }

• W3049361319 endingPage "3521" @default.
• W3049361319 startingPage "3512" @default.
• W3049361319 abstract "Podocyte injury is a common cause of massive proteinuria. Astragaloside IV (AS-IV) has been reported to protect podocytes in diabetic models. However, the effects and potential mechanism of AS-IV on puromycin aminonucleoside (PAN)-induced podocyte injury remains unclear. The aim of the present study was to investigate the protective effect of AS-IV on PAN-induced podocyte injury both in vivo and in vitro. In vivo, we induced a podocytic-injury model in rats via a single tail vein injection of PAN. The rats in the treatment group received AS-IV intragastrically (i.g.) at a dose of 40 mg/kg/day for 10 days. At the end of the experiment, 24 h urine, serum and kidney samples were collected for examination. In vitro, we injured podocytes with 30 μg/ml PAN and treated them with AS-IV at concentrations of 5, 25 and 50 μg/ml. Next, we analyzed podocyte protein expression and the Wnt/planar-cell polarity (PCP) pathway using western blot and immunofluorescence (IF). Our results showed that AS-IV decreased proteinuria in PAN-injured rats, and restored specific protein expression in podocytes. In PAN-induced injuries to human podocytes, AS-IV restored the expression and distribution of F-actin and synaptopodin, and repaired the morphology of the actin-based cytoskeleton. Notably, AS-IV could activate the Wnt/PCP pathway by promoting expression of Wnt5a, protein tyrosine kinase 7 (PTK7), Rho-associated coiled-coil-containing protein kinase 1 (ROCK1), Ras-related C3 botulinum toxin substrate 1 (Rac1) and phospho-SAPK/JNK (Thr183/Tyr185) (p-JNK) in vivo and in vitro. In conclusion, we demonstrated that AS-IV alleviated PAN-induced injury to the podocyte cytoskeleton, partially by activating the Wnt/PCP pathway." @default.
• W3049361319 created "2020-08-21" @default.
• W3049361319 creator A5003967728 @default.
• W3049361319 creator A5014124513 @default.
• W3049361319 creator A5024820288 @default.
• W3049361319 creator A5045473616 @default.
• W3049361319 creator A5047899405 @default.
• W3049361319 creator A5068861463 @default.
• W3049361319 creator A5075079298 @default.
• W3049361319 creator A5089257398 @default.
• W3049361319 date "2020-01-01" @default.
• W3049361319 modified "2023-10-03" @default.
• W3049361319 title "Astragaloside IV alleviates puromycin aminonucleoside-induced podocyte cytoskeleton injury through the Wnt/PCP pathway." @default.
• W3049361319 cites W1602743220 @default.
• W3049361319 cites W1769943683 @default.
• W3049361319 cites W1971498397 @default.
• W3049361319 cites W1973537879 @default.
• W3049361319 cites W1974520977 @default.
• W3049361319 cites W1978789471 @default.
• W3049361319 cites W1981012330 @default.
• W3049361319 cites W1984987328 @default.
• W3049361319 cites W1985804361 @default.
• W3049361319 cites W1991461487 @default.
• W3049361319 cites W2016240460 @default.
• W3049361319 cites W2016423968 @default.
• W3049361319 cites W2031787550 @default.
• W3049361319 cites W2032894029 @default.
• W3049361319 cites W2043912973 @default.
• W3049361319 cites W2082405869 @default.
• W3049361319 cites W2089156332 @default.
• W3049361319 cites W2100408851 @default.
• W3049361319 cites W2100461039 @default.
• W3049361319 cites W2103668136 @default.
• W3049361319 cites W2105277147 @default.
• W3049361319 cites W2119092984 @default.
• W3049361319 cites W2121228024 @default.
• W3049361319 cites W2123409869 @default.
• W3049361319 cites W2124485554 @default.
• W3049361319 cites W2127251425 @default.
• W3049361319 cites W2137997062 @default.
• W3049361319 cites W2140225613 @default.
• W3049361319 cites W2162059081 @default.
• W3049361319 cites W2270741943 @default.
• W3049361319 cites W2306964516 @default.
• W3049361319 cites W2507547513 @default.
• W3049361319 cites W2606888265 @default.
• W3049361319 cites W2765676808 @default.
• W3049361319 cites W2885582869 @default.
• W3049361319 cites W2899500948 @default.
• W3049361319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7407721" @default.
• W3049361319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32774716" @default.
• W3049361319 hasPublicationYear "2020" @default.
• W3049361319 type Work @default.
• W3049361319 sameAs 3049361319 @default.
• W3049361319 citedByCount "2" @default.
• W3049361319 countsByYear W30493613192022 @default.
• W3049361319 crossrefType "journal-article" @default.
• W3049361319 hasAuthorship W3049361319A5003967728 @default.
• W3049361319 hasAuthorship W3049361319A5014124513 @default.
• W3049361319 hasAuthorship W3049361319A5024820288 @default.
• W3049361319 hasAuthorship W3049361319A5045473616 @default.
• W3049361319 hasAuthorship W3049361319A5047899405 @default.
• W3049361319 hasAuthorship W3049361319A5068861463 @default.
• W3049361319 hasAuthorship W3049361319A5075079298 @default.
• W3049361319 hasAuthorship W3049361319A5089257398 @default.
• W3049361319 hasConcept C104317684 @default.
• W3049361319 hasConcept C126322002 @default.
• W3049361319 hasConcept C133717845 @default.
• W3049361319 hasConcept C137620995 @default.
• W3049361319 hasConcept C142669718 @default.
• W3049361319 hasConcept C1491633281 @default.
• W3049361319 hasConcept C153911025 @default.
• W3049361319 hasConcept C185592680 @default.
• W3049361319 hasConcept C2776415932 @default.
• W3049361319 hasConcept C2776855237 @default.
• W3049361319 hasConcept C2777093181 @default.
• W3049361319 hasConcept C2777146197 @default.
• W3049361319 hasConcept C2779561371 @default.
• W3049361319 hasConcept C2780091579 @default.
• W3049361319 hasConcept C2781156571 @default.
• W3049361319 hasConcept C2910727860 @default.
• W3049361319 hasConcept C2993400109 @default.
• W3049361319 hasConcept C55493867 @default.
• W3049361319 hasConcept C62478195 @default.
• W3049361319 hasConcept C71924100 @default.
• W3049361319 hasConcept C86803240 @default.
• W3049361319 hasConcept C95444343 @default.
• W3049361319 hasConcept C98274493 @default.
• W3049361319 hasConceptScore W3049361319C104317684 @default.
• W3049361319 hasConceptScore W3049361319C126322002 @default.
• W3049361319 hasConceptScore W3049361319C133717845 @default.
• W3049361319 hasConceptScore W3049361319C137620995 @default.
• W3049361319 hasConceptScore W3049361319C142669718 @default.
• W3049361319 hasConceptScore W3049361319C1491633281 @default.
• W3049361319 hasConceptScore W3049361319C153911025 @default.
• W3049361319 hasConceptScore W3049361319C185592680 @default.
• W3049361319 hasConceptScore W3049361319C2776415932 @default.
• W3049361319 hasConceptScore W3049361319C2776855237 @default.

• next